Sesen Bio Inc
Change company Symbol lookup
Select an option...
SESN Sesen Bio Inc
KRTX Karuna Therapeutics Inc
SNSE Sensei Biotherapeutics Inc
ALGS Aligos Therapeutics Inc
SRRA Sierra Oncology Inc
ATOS Atossa Therapeutics Inc
OSMT Osmotica Pharmaceuticals PLC
SAND Sandstorm Gold Ltd
GRVI Grove Inc
STON Stonemor Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Sesen Bio, Inc. is a late-stage clinical company providing targeted fusion protein therapeutics (TFPTs) for the treatment of patients with cancer. Its product pipeline includes Vicinium, which is composed of an anti-epithelial cell adhesion molecule (EpCAM) antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). The Company's product candidates are based on its TFPT platform and are focused on addressing areas of unmet medical need in cancer. TFPTs are single protein therapeutics composed of targeting domains genetically fused via peptide linkers to cytotoxic protein payloads that are produced through its recombinant one-step, microbial manufacturing process.

Price
Delayed
$1.08
Day's Change
-0.0129 (-1.18%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.10
Day's Low
1.05
Volume
(Heavy Day)

Today's volume of 1,147,587 shares is on pace to be much greater than SESN's 10-day average volume of 4,398,811 shares.

1,147,587
  • Prev Close
    1.09
  • Today's Open
    1.09
  • Day's Range
    1.05-1.10
  • Avg Vol (10-day)
    4.4M
  • Last (time)
    10:21a ET 12/08/21
  • Last (size)
    100
  • 52-Wk Range
    0.70 - 6.04
    LowHigh
  • (08/13/21 - 08/13/21)
    53.87%
  • 140.0%
  • Market Cap
    209.4M
  • Shares Outstanding
    199.5M
  • -0.26
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.6
  • 23.59
  • (% of float 11/15/21)
    5.04

Latest News

December 08, 2021
9:28 am ET
Zacks
November 29, 2021
8:00 am ET
BusinessWire
November 23, 2021
8:00 am ET
BusinessWire
November 08, 2021
8:00 am ET
BusinessWire
November 01, 2021
8:00 am ET
BusinessWire
October 25, 2021
9:31 am ET
PR Newswire
October 20, 2021
8:35 am ET
PR Newswire
October 18, 2021
11:36 am ET
Accesswire
10:01 am ET
Newsfile
9:31 am ET
Accesswire
9:23 am ET
Newsfile
8:31 am ET
Accesswire
5:19 am ET
Newsfile
October 17, 2021
4:00 pm ET
PR Newswire
2:15 pm ET
Globe Newswire
10:21 am ET
Accesswire
10:00 am ET
Newsfile
8:33 am ET
Newsfile
8:33 am ET
Globe Newswire
October 16, 2021
7:47 pm ET
Accesswire
11:09 am ET
Accesswire
10:08 am ET
Globe Newswire
October 15, 2021
10:50 pm ET
BusinessWire
9:00 pm ET
BusinessWire
7:37 pm ET
Accesswire
6:36 pm ET
Newsfile
5:58 pm ET
Accesswire
4:28 pm ET
Newsfile
3:54 pm ET
Newsfile
3:30 pm ET
Accesswire
3:00 pm ET
Newsfile
1:10 pm ET
BusinessWire
1:00 pm ET
Globe Newswire
9:01 am ET
Accesswire
9:00 am ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.